ROG (52) NGVT (68) KWR (56) WDFC (75) ⌘ Pro Terminal →

Innospec Inc. (IOSP) — RQD Stock Rating Cockpit

$101.41 +0.71% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $101.78

Innospec Inc. (IOSP) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (28% profit margin, 10% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate) →

ROARABLE B- • BUY Cap $2.50B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $101.79 (+0.37%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 7.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B-

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IOSP)Realized 20D OHLCV Swing Band: ±4.1%

Deterministic 5-Pillar Attribution (70/100 Composite)

🔍 WHY IOSP SCORES 70/100 (B-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+16/20 pts (23% of score)

FRED Regime × Technicals: 98% of 52W Range • RSI-14 at 59.5 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: Cash Engine Quality+14/20 pts (20% of score)

SEC XBRL FY 2025 (10-K): 7.8% FCF Margin ($138.3M FCF) & 27.7% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution13/20 pts (-7 pt drag)

Cannibal Buyback (-1.52% YoY Shares) & executive Form 4 sales trim 7 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$95.65+1.2% Next Q

Q2 (-2Q)

Grade C+$96.81+1.9% Next Q

Q3 (-1Q)

Grade B-$98.64+2.8% Next Q

Current

Grade B-$101.41+6.6% Hist 90D α

Trajectory: C+ (62) → B- (70)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the IOSP Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 70/100 (B-) score, IOSP faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 25.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($96.04) or 200D SMA ($84.37) invalidates the momentum regime and cuts Target Base ($106.89) toward Bear Floor ($83.16).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $IOSP• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “IOSP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 70%NO 30%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

59.530 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

5.47>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

4 / 99-Pt Accounting

52-WEEK LASER RANGE98% OF RANGE

L: $66$101.41H: $102

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (28% profit margin), though cash flow growth is moderate rather than explosive right now.

Factor Grade: B-RQD 14 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 26 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: BRQD 30 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bullish on IOSP

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (70)

9.9% ROIC with 27.7% gross margin and 5.54% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (70)

Altman-Z 5.47 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BULLISH (70)

26/40 institutional & smart-money positioning score with 16/20 macro alignment.

Bull Case: Why Buyers Like IOSP

✓Established market leader in Materials with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Broader market pullbacks can still drag down strong stocks in the short run.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (IOSP Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

IOSP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +32.98%▲ ASCENDING CHANNEL

2026-10-30O $101.5H $102.0L $99.46C $101.4VOL 216.5K

RES: $104.7SUP: $87.39SMA50: $96.04SMA200: $84.37

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

IOSP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 IOSP Butterfly Map → + Track IOSP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

14.9%/yr Implied 5Y Growth

vs. -3.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on IOSP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for IOSP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for IOSP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IOSP)

Materials Rank #15 of 270 ⚔️ ROG vs IOSP Full Matrix →

1. Head-to-Head Materials Peer Comparison (IOSP vs. ROG, NGVT, KWR, WDFC)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Innospec Inc. (IOSP) ranks #15 by composite RQD confidence (70/100, grade B-) and #103 by equity capitalization ($2.50B). Within this direct 5-issuer industry benchmark cohort, WDFC leads on earnings valuation at 32.3x trailing P/E, while NGVT leads on capital efficiency and profitability with 85.0% ROIC and 39.5% gross margin. WDFC currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with IOSP at 70/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
IOSP ACTIVE Innospec Inc.	B-	70/100	—	27.7%	9.9%	+0.71%	$2.50B	Benchmark Subject
ROG Rogers Corporation	D+	52/100	—	31.7%	-3.6%	-0.33%	$2.50B	/rog-vs-iosp →
NGVT Ingevity Corporation	C+	68/100	—	39.5%	85.0%	+1.62%	$2.59B	/ngvt-vs-iosp →
KWR Quaker Houghton	D+	56/100	—	36.0%	2.1%	+0.61%	$2.72B	/kwr-vs-iosp →
WDFC WD-40 Company	B	75/100	32.3x	55.1%	27.2%	+2.49%	$2.94B	/wdfc-vs-iosp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001054905

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Innospec Inc. (IOSP) reported GAAP revenue of $1.78B (-3.7% vs. FY2024 revenue of $1.85B , and -8.8% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $138.3M, and free cash flow of $138.3M (-25.0% YoY). On the balance sheet, IOSP closed FY2025 with $1.83B in total assets against $0 in total debt (Altman Z-Score: 5.47, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.78B	$0	$138.3M	$138.3M	$1.83B	—
FY2024 (FY)	2024-12-31	$1.85B	$0	$184.5M	$184.5M	$1.73B	—
FY2023 (FY)	2023-12-31	$1.95B	$0	$207.3M	$207.3M	—	—

3. IOSP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is IOSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Innospec Inc. (NASDAQ: IOSP) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $101.41 (+0.71% 1D, market cap $2.50B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 13/20. Across 270 tracked Materials issuers, IOSP ranks #15 in composite RQD confidence.

How does IOSP compare to ROG and NGVT in the Materials sector?

Within the Materials sector (Major Chemicals), IOSP carries a Roarable B- (70/100 RQD), trailing P/E of N/A, gross margin of 27.7%, and ROIC of 9.9%. By comparison, ROG (Rogers Corporation) holds a D+ grade (52/100 RQD, P/E N/A, ROIC -3.6%, cap $2.50B) and NGVT (Ingevity Corporation) posts a C+ grade (68/100 RQD, P/E N/A, ROIC 85.0%, cap $2.59B). Among the 5-stock peer group, WDFC leads on earnings multiple (32.3x) while NGVT leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for IOSP?

Per IOSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001054905), Innospec Inc. generated $1.78B in revenue (-3.7% YoY), $0 in net income, and $138.3M in free cash flow against $1.83B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is IOSP trading relative to its 50-day, 200-day, and 52-week technical levels?

IOSP last traded at $101.41 (+0.71% on volume of 205,113 shares), positioning the stock +5.59% above its 50-day simple moving average ($96.04) and +20.20% above its 200-day simple moving average ($84.37). Across its 52-week range of $65.51 to $102.00, IOSP sits at the 98.4% percentile with a 14-day RSI of 59.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±4.1% ($97.25 to $105.57).

IOSP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell IOSP stock right now?

Innospec Inc. (IOSP) currently earns a Roarable Rating of B- (Buy — BUY) with 70/100 RQD Confidence. High-quality cash engine (28% profit margin, 10% return on capital) with steady institutional support.

What is IOSP's 12-month price target and RQD AI Jury consensus?

IOSP's 12-month base price target is $106.89 (range $83.16 to $126.13), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: IOSP RQD Cockpit IOSP 12M Forecast IOSP Earnings & Move IOSP Dividends & DRIP IOSP Insiders & 13F IOSP Whale Options IOSP Profit Sankey IOSP News & Why